1. Home
  2. ALUR vs COHN Comparison

ALUR vs COHN Comparison

Compare ALUR & COHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALUR
  • COHN
  • Stock Information
  • Founded
  • ALUR 2009
  • COHN 1999
  • Country
  • ALUR United States
  • COHN United States
  • Employees
  • ALUR N/A
  • COHN N/A
  • Industry
  • ALUR
  • COHN Investment Bankers/Brokers/Service
  • Sector
  • ALUR
  • COHN Finance
  • Exchange
  • ALUR Nasdaq
  • COHN Nasdaq
  • Market Cap
  • ALUR 19.1M
  • COHN 17.8M
  • IPO Year
  • ALUR N/A
  • COHN N/A
  • Fundamental
  • Price
  • ALUR $3.35
  • COHN $8.10
  • Analyst Decision
  • ALUR Strong Buy
  • COHN
  • Analyst Count
  • ALUR 3
  • COHN 0
  • Target Price
  • ALUR $22.83
  • COHN N/A
  • AVG Volume (30 Days)
  • ALUR 4.1M
  • COHN 8.4K
  • Earning Date
  • ALUR 03-26-2025
  • COHN 03-10-2025
  • Dividend Yield
  • ALUR N/A
  • COHN 12.33%
  • EPS Growth
  • ALUR N/A
  • COHN N/A
  • EPS
  • ALUR N/A
  • COHN N/A
  • Revenue
  • ALUR $32,110,000.00
  • COHN $73,777,000.00
  • Revenue This Year
  • ALUR $2.18
  • COHN N/A
  • Revenue Next Year
  • ALUR $35.85
  • COHN N/A
  • P/E Ratio
  • ALUR N/A
  • COHN N/A
  • Revenue Growth
  • ALUR N/A
  • COHN N/A
  • 52 Week Low
  • ALUR $2.15
  • COHN $6.10
  • 52 Week High
  • ALUR $98.75
  • COHN $12.82
  • Technical
  • Relative Strength Index (RSI)
  • ALUR 51.19
  • COHN 39.00
  • Support Level
  • ALUR $2.72
  • COHN $8.01
  • Resistance Level
  • ALUR $3.50
  • COHN $8.49
  • Average True Range (ATR)
  • ALUR 0.40
  • COHN 0.43
  • MACD
  • ALUR 0.18
  • COHN -0.01
  • Stochastic Oscillator
  • ALUR 56.99
  • COHN 30.51

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

Share on Social Networks: